Lipid screening and cardiovascular health in childhood

SR Daniels, FR Greer, Committee on Nutrition - Pediatrics, 2008 - publications.aap.org
This Clinical Report was retired May 2012. This clinical report replaces the 1998 policy
statement from the American Academy of Pediatrics on cholesterol in childhood, which has …

Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association expert panel on population and prevention …

REW Kavey, V Allada, SR Daniels, LL Hayman… - Circulation, 2006 - Am Heart Assoc
Although for most children the process of atherosclerosis is subclinical, dramatically
accelerated atherosclerosis occurs in some pediatric disease states, with clinical coronary …

American Association of Clinical Endocrinologists and American College of Endocrinology guidelines for management of dyslipidemia and prevention of …

PS Jellinger, Y Handelsman, PD Rosenblit… - Endocrine Practice, 2017 - Elsevier
Objective The development of these guidelines is mandated by the American Association of
Clinical Endocrinologists (AACE) Board of Directors and American College of Endocrinology …

American Association of Clinical Endocrinologists' guidelines for management of dyslipidemia and prevention of atherosclerosis

PS Jellinger, DA Smith, AE Mehta, O Ganda… - Endocrine …, 2012 - endocrinepractice.org
METHODS This CPG was developed in accordance with the AACE Protocol for
Standardized Production of Clinical Practice Guidelines—2010 Update (

Patient adherence and medical treatment outcomes: a meta-analysis

MR DiMatteo, PJ Giordani, HS Lepper… - Medical care, 2002 - journals.lww.com
Background. Adherence is a factor in the outcome of medical treatment, but the strength and
moderators of the adherence-outcome association have not been systematically assessed …

Statins for children with familial hypercholesterolemia

A Vuorio, J Kuoppala, PT Kovanen… - Cochrane Database …, 2017 - cochranelibrary.com
Background Familial hypercholesterolemia is one of the most common inherited metabolic
diseases and is an autosomal dominant disorder meaning heterozygotes, or carriers, are …

Guidelines for the diagnosis and treatment of pediatric familial hypercholesterolemia 2022

M Harada-Shiba, A Ohtake, D Sugiyama… - … of atherosclerosis and …, 2023 - jstage.jst.go.jp
As atherosclerosis begins in childhood, early diagnosis and treatment of familial
hypercholesterolemia (FH) is considered necessary. The basic diagnosis of pediatric FH …

Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial

A Wiegman, BA Hutten, E De Groot, J Rodenburg… - Jama, 2004 - jamanetwork.com
ContextChildren with familial hypercholesterolemia have endothelial dysfunction and
increased carotid intima-media thickness (IMT), which herald the premature atherosclerotic …

Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2022

T Okamura, K Tsukamoto, H Arai, Y Fujioka… - … of Atherosclerosis and …, 2024 - jstage.jst.go.jp
In Japan, a super-aged society, deaths from atherosclerotic cardiovascular disease
(ASCVD), especially cardiac diseases including coronary artery disease (CAD) such as …

[PDF][PDF] Lovastatin corrects excess protein synthesis and prevents epileptogenesis in a mouse model of fragile X syndrome

EK Osterweil, SC Chuang, AA Chubykin, M Sidorov… - Neuron, 2013 - cell.com
Many neuropsychiatric symptoms of fragile X syndrome (FXS) are believed to be a
consequence of altered regulation of protein synthesis at synapses. We discovered that …